Navidea drops rheumatoid arthritis programme after failed Phase III trial
Exploratory analysis of Lymphoseek failed to predict which rheumatoid arthritis patients would respond to treatment with anti-TNFα therapy.
Clinical Trials Arena
Aerovate slashes workforce after failed Phase IIb trial
Ethris shares positive data with mRNA drug following new funding
Tandem showcases data from user survey of Tandem Mobi
Insights on May: US Osteoporosis Awareness and Prevention Month
Breyanzi battles CAR-T rivals with back-to-back approvals in lymphoma
Too old for paediatric trials, too young for adult trials
Clinical Trials In Oncology West Coast 2024: Patient experience front and centre
